The neutral Ru(II) complex κP-[RuCl 2 (η 6 -p-cymene)(CAP)] (1), and the two ionic complexes κP-[RuCl(η 6 -p-cymene)(MeCN)(CAP)]PF 6 (2) and κP-[RuCl(η 6 -p-cymene)(CAP) 2 ]PF 6 (3), containing the water-soluble phosphine 1,4,7-triaza-9-phosphatricyclo[5.3.2.1]tridecane (CAP), were tested as catalysts for homogeneous hydrogenation of benzylidene acetone, selectively producing the saturated ketone as product. The catalytic tests were carried out in aqueous phase under transfer hydrogenation conditions, at mild temperatures using sodium formate as hydrogen source. Complex 3, which showed the highest stability under the reaction conditions applied, was also tested for C=N bond reduction from selected cyclic imines. Preliminary NMR studies run under pseudo-catalytic conditions starting from 3 showed the formation of κP-[RuH(η 6 -p-cymene)(CAP) 2 ]PF 6 (4) as the pivotal species in catalysis.
Introduction
The importance of ruthenium compounds as homogeneous catalysts for the synthesis of fine chemicals and pharmaceutical intermediates has been widely demonstrated [1] [2] [3] [4] [5] . Some of them display high reactivity and selectivity in many catalytic transformations and, in particular, in the hydrogenation of different unsaturated compounds, such as α,β-unsaturated ketones and imines, using molecular H 2 and transfer hydrogenation (TH) protocols as reducing agents [6] [7] [8] [9] . The employment of these last methodologies offers attractive advantages including the use of inexpensive and easy to handle hydrogen donors instead of explosive hydrogen gas, mild reaction conditions, and the possibility of using environmentally friendly solvents such as water [10] [11] [12] . The development of metal complexes containing water soluble ligands is the most common strategy to perform catalytic hydrogenations in water or under aqueous biphasic conditions and many organophosphines have been prepared for this purpose [13, 14] .
The water soluble phosphine 1,3,5-triaza-7-phospaadamantane (PTA, Figure 1 ) and its derivatives found large use as ligands for transition metal complexes active in homogeneous aqueous phase and biphasic catalysis and in the course of last decade many reports concerning Ru-PTA catalysts appeared in the literature [15] [16] [17] . For example, cyclopentadienyl (Cp) and pentamethylcyclopentadienyl (Cp*) Ru(II) complexes such as [RuCpCl(PTA) 2 ], [RuCp(MeCN)(PTA) 2 ](PF 6 ), [RuCp*Cl(PTA) 2 ], active catalysts for the hydrogenation of benzylidene acetone (BZA) under H2 pressure in a biphasic water/octane solvent mixture showing a high chemoselectivity to C=C double bond reduction [18, 19] .
Another class of catalytically active compounds is represented by [RuCl2(η 6 -p-cymene)(PTA)] (RAPTA-C) and [RuCl(η 6 -p-cymene)(PTA)2](BF4), which were shown to be active catalysts for the full hydrogenation of various substituted arenes into the corresponding cyclohexanes under biphasic conditions [20] . Some Ru(II) complexes bearing 'upper rim' PTA derivatives-i.e., pending arms on the C atom adjacent to the P donor ( Figure 1 )-were also tested in catalytic hydrogenation of acetophenone giving good conversions even at room temperature using protocols based on the presence of both H2 gas and t BuOK/ i PrOH [21] . Recently, we reported on the synthesis of a new class of half-sandwich ruthenium arene complexes bearing a higher homologue of PTA, namely 1,4,7-triaza-9-phosphatricyclo[5.3.2.1]tridecane, CAP [22] . As PTA, this compound is a white, air-stable solid under standard conditions, and it is moderately water soluble with S(H2O)25 °C = 20 g L −1 , about one order of magnitude lower than for PTA. Although structurally very similar to PTA, CAP has a higher cage flexibility due to the presence of two CH2 spacers between the N atoms instead of one [23, 24] . The Ru(II) complex κP-[RuCl2(η 6 -p-cymene)(CAP)] (1, Figure 2 ) was obtained by reacting [RuCl2(η 6 -p-cymene)]2 with 2 equiv. of CAP in CH2Cl2 at room temperature. The two cationic complexes κP-[RuCl(η 6 -p-cymene)(MeCN)(CAP)](PF6) (2) and κP-[RuCl(η 6 -p-cymene)(CAP)2](PF6) (3, Figure 2 ) were synthesized by chloride abstraction from 1 with TlPF6 either in the presence of MeCN or a second equivalent of CAP, respectively. These compounds were tested in vitro for their cytotoxic activity against selected cancer cell lines with good results [22] . [22] .
Based on the good catalytic properties shown by Ru(II) arene PTA complexes, we tested complexes 1−3 as catalysts for the reduction of α,β-unsaturated compounds by a mild TH protocol (HCOONa/H2O/MeOH), choosing BZA as model substrate. Complex 3 was also tested under the same conditions for the C=N bond hydrogenation of selected cyclic imines to produce the corresponding amines. Recently, we reported on the synthesis of a new class of half-sandwich ruthenium arene complexes bearing a higher homologue of PTA, namely 1,4,7-triaza-9-phosphatricyclo[5.3.2.1]tridecane, CAP [22] . As PTA, this compound is a white, air-stable solid under standard conditions, and it is moderately water soluble with S(H 2 O) 25 • C = 20 g L −1 , about one order of magnitude lower than for PTA. Although structurally very similar to PTA, CAP has a higher cage flexibility due to the presence of two CH 2 spacers between the N atoms instead of one [23, 24] . The Ru(II) complex κP-[RuCl 2 (η 6 -p-cymene)(CAP)] (1, Figure 2 ) was obtained by reacting [RuCl 2 (η 6 -p-cymene)] 2 with 2 equiv. of CAP in CH 2 Cl 2 at room temperature. The two cationic complexes κP-[RuCl(η 6 -p-cymene)(MeCN)(CAP)](PF 6 ) (2) and κP-[RuCl(η 6 -p-cymene)(CAP) 2 ](PF 6 ) (3, Figure 2 ) were synthesized by chloride abstraction from 1 with TlPF 6 either in the presence of MeCN or a second equivalent of CAP, respectively. These compounds were tested in vitro for their cytotoxic activity against selected cancer cell lines with good results [22] . [20] . Some Ru(II) complexes bearing 'upper rim' PTA derivatives-i.e., pending arms on the C atom adjacent to the P donor ( Figure 1 )-were also tested in catalytic hydrogenation of acetophenone giving good conversions even at room temperature using protocols based on the presence of both H2 gas and t BuOK/ i PrOH [21] . Recently, we reported on the synthesis of a new class of half-sandwich ruthenium arene complexes bearing a higher homologue of PTA, namely 1,4,7-triaza-9-phosphatricyclo[5.3.2.1]tridecane, CAP [22] . As PTA, this compound is a white, air-stable solid under standard conditions, and it is moderately water soluble with S(H2O)25 °C = 20 g L −1 , about one order of magnitude lower than for PTA. Although structurally very similar to PTA, CAP has a higher cage flexibility due to the presence of two CH2 spacers between the N atoms instead of one [23, 24] . The Ru(II) complex κP-[RuCl2(η 6 -p-cymene)(CAP)] (1, Figure 2 ) was obtained by reacting [RuCl2(η 6 -p-cymene)]2 with 2 equiv. of CAP in CH2Cl2 at room temperature. The two cationic complexes κP-[RuCl(η 6 -p-cymene)(MeCN)(CAP)](PF6) (2) and κP-[RuCl(η 6 -p-cymene)(CAP)2](PF6) (3, Figure 2 ) were synthesized by chloride abstraction from 1 with TlPF6 either in the presence of MeCN or a second equivalent of CAP, respectively. These compounds were tested in vitro for their cytotoxic activity against selected cancer cell lines with good results [22] . Based on the good catalytic properties shown by Ru(II) arene PTA complexes, we tested complexes 1−3 as catalysts for the reduction of α,β-unsaturated compounds by a mild TH protocol (HCOONa/H2O/MeOH), choosing BZA as model substrate. Complex 3 was also tested under the same conditions for the C=N bond hydrogenation of selected cyclic imines to produce the corresponding amines. Based on the good catalytic properties shown by Ru(II) arene PTA complexes, we tested complexes 1-3 as catalysts for the reduction of α,β-unsaturated compounds by a mild TH protocol (HCOONa/H 2 O/MeOH), choosing BZA as model substrate. Complex 3 was also tested under the same conditions for the C=N bond hydrogenation of selected cyclic imines to produce the corresponding amines. Finally, in order to clarify the nature of catalytically active species involved in the hydrogenation process, some preliminary mechanistic NMR experiments under pseudo-catalytic conditions were run starting from 3 and the results are presented below.
Results

Catalytic Transfer Hydrogenation of BZA
As discussed above, several Ru(II) complexes including PTA and derivatives have been used as homogeneous catalysts for hydrogenation of a wide variety of unsaturated substrates [15] [16] [17] . We selected benzylidene acetone (BZA) as model substrate for α,β-unsaturated ketones hydrogenation (Scheme 1) and tested compounds 1-3 as catalysts using a TH protocol involving HCOONa/H 2 O with a standard catalyst/substrate/formate ratio of 1:100:1000. Finally, in order to clarify the nature of catalytically active species involved in the hydrogenation process, some preliminary mechanistic NMR experiments under pseudo-catalytic conditions were run starting from 3 and the results are presented below.
Results
Catalytic Transfer Hydrogenation of BZA
As discussed above, several Ru(II) complexes including PTA and derivatives have been used as homogeneous catalysts for hydrogenation of a wide variety of unsaturated substrates [15] [16] [17] . We selected benzylidene acetone (BZA) as model substrate for α,β-unsaturated ketones hydrogenation (Scheme 1) and tested compounds 1−3 as catalysts using a TH protocol involving HCOONa/H2O with a standard catalyst/substrate/formate ratio of 1:100:1000.
Scheme 1. Hydrogenation of benzylidene acetone (BZA).
Sodium formate was chosen as it is one of the mildest reducing agents with large compatibility with various functional groups, also having good water solubility. To facilitate the formation of a homogeneous liquid phase and to ensure complete solubility of all reagents, the tests were carried out in a water/methanol 1:1 mixture. The results are summarized in Table 1 . At first, the catalytic run was carried out at 60 °C in the presence of complex 1 (entry 1) showing a conversion of 60% after 24 h and a ca. 3.5:1 ratio between the saturated ketone (A) and the unsaturated alcohol (B). When the temperature was raised to 80 °C (entry 3), the conversion reached 99.4% after 4 h only. A high conversion of 82.6% was also observed with 2 after 4 h reaction under the same conditions (entry 5), also in this case with high selectivity (83.4%) towards the saturated ketone. However, darkening of the reaction mixture and the appearance of a black precipitate during tests run either at 60 °C or 80 °C with both catalysts 1 and 2 suggested that these complexes Sodium formate was chosen as it is one of the mildest reducing agents with large compatibility with various functional groups, also having good water solubility. To facilitate the formation of a homogeneous liquid phase and to ensure complete solubility of all reagents, the tests were carried out in a water/methanol 1:1 mixture. The results are summarized in Table 1 . At first, the catalytic run was carried out at 60 • C in the presence of complex 1 (entry 1) showing a conversion of 60% after 24 h and a ca. 3.5:1 ratio between the saturated ketone (A) and the unsaturated alcohol (B). When the temperature was raised to 80 • C (entry 3), the conversion reached 99.4% after 4 h only. A high conversion of 82.6% was also observed with 2 after 4 h reaction under the same conditions (entry 5), also in this case with high selectivity (83.4%) towards the saturated ketone. However, darkening of the reaction mixture and the appearance of a black precipitate during tests run either at 60 • C or 80 • C with both catalysts 1 and 2 suggested that these complexes were at least partially decomposing under these conditions. This was confirmed by repeating the runs using the standard Hg(0) poisoning test which resulted in the reduction of the catalytic activity. This was particularly evident for complex 2, with an important decrease of conversion after 4 h at 80 • C (51.9%, entry 6, vs. 82.6%, entry 5).
For comparison, we tested complex RAPTA-C, i.e., the PTA analogue of 1, under the same reaction conditions as in Table 1 , entry 3. Also in this case a substantial drop of conversion was observed in the presence of Hg (30%, entry 10, vs. 99.5% without Hg, entry 9), indicating that a significant degree of decomposition leading to undefined catalytically active phosphine-free species was probably occurring also in the case of RAPTA-C.
Complex 3 was then tested and showed to be more stable than 1 and 2 under the catalytic conditions applied as no black precipitate was observed during the catalytic runs even after 48 h at 80 • C. The catalytic activity was only slightly reduced in the presence of Hg(0), giving 92.5% BZA conversion after 48 h at 80 • C (entry 8) compared to the 96.0% achieved in the test run without addition of mercury (entry 7). The higher stability was accompanied by a lower reaction rate to have almost complete conversion that was reached only after 48 h at 80 • C. On the other hand, the choice of this higher temperature resulted to be essential to achieve good activity with 3, as only 7.7% BZA conversion was obtained after 24 h in tests run at 60 • C.
As with 1 and 2, complex 3 also proved to be a rather chemoselective catalyst for C=C bond hydrogenation, converting BZA mainly to the saturated ketone 4-phenyl-butan-2-one (A) with a selectivity of 71.5% at 92.5% conversion after 48 h.
As an example of cyclic α,β-unsaturated ketone, 2-cyclohexen-1-one was used as substrate. In the case of complex 1, after 4 h at 80 • C using the standard conditions for TH described above, the almost complete conversion was observed. However, mainly cyclohexanol (62.9%) was obtained, demonstrating poor chemoselectivity to either C=C or C=O bond reduction. Moreover, a non-negligible amount of cyclohexanone dimethyl ketal (ca. 36.6%) was identified in solution by GC-MS at the end of the run, suggesting that C=O bond protection was competing with hydrogenation under these conditions. When the tests were performed with catalyst 3, low yields (ca. 1%) of hydrogenation products were observed after 24 h at 80 • C. The formation of the corresponding ketal was again observed (ca. 27%).
Transfer Hydrogenation of Cyclic Imines
Hydrogenation of imines and, in particular, cyclic imines is a worthy synthetic tool to obtain amines, that in turn are synthetic intermediates of great importance especially in pharmaceutical industry [25] . Among Ru catalysts described in the literature for this class of homogeneously catalyzed reaction, outstanding performances were obtained for example with Noyori's complex [RuCl(η 6 -p-cymene)(TsDPEN)] (TsDPEN=N-(p-toluene-sulfonyl)-1,2-diphenylethylenediamine), using a formic acid-triethylamine azeotropic mixture as reducing agent [26, 27] . Examples of water soluble ruthenium-arene catalysts for TH of imines in aqueous phase with HCOONa are also known [28, 29] . For cyclic imines hydrogenation, we also described an efficient system based on a heterogenized Ir(I) complex bearing PTA supported into an ion-exchange resin, using water and H 2 pressure [30] .
On the basis of the higher stability demonstrated by complex 3 compared to 1 and 2 under the catalytic conditions previously discussed, this compound was selected as a catalyst for tests in TH of the cyclic imines shown in Table 2 . were at least partially decomposing under these conditions. This was confirmed by repeating the runs using the standard Hg(0) poisoning test which resulted in the reduction of the catalytic activity. This was particularly evident for complex 2, with an important decrease of conversion after 4 h at 80 °C (51.9%, entry 6, vs. 82.6%, entry 5).
For comparison, we tested complex RAPTA-C, i.e. the PTA analogue of 1, under the same reaction conditions as in Table 1 , entry 3. Also in this case a substantial drop of conversion was observed in the presence of Hg (30%, entry 10, vs. 99.5% without Hg, entry 9), indicating that a significant degree of decomposition leading to undefined catalytically active phosphine-free species was probably occurring also in the case of RAPTA-C.
Complex 3 was then tested and showed to be more stable than 1 and 2 under the catalytic conditions applied as no black precipitate was observed during the catalytic runs even after 48 h at 80 °C. The catalytic activity was only slightly reduced in the presence of Hg(0), giving 92.5% BZA conversion after 48 h at 80 °C (entry 8) compared to the 96.0% achieved in the test run without addition of mercury (entry 7). The higher stability was accompanied by a lower reaction rate to have almost complete conversion that was reached only after 48 h at 80 °C. On the other hand, the choice of this higher temperature resulted to be essential to achieve good activity with 3, as only 7.7% BZA conversion was obtained after 24 h in tests run at 60 °C.
As an example of cyclic α,β-unsaturated ketone, 2-cyclohexen-1-one was used as substrate. In the case of complex 1, after 4 h at 80 °C using the standard conditions for TH described above, the almost complete conversion was observed. However, mainly cyclohexanol (62.9%) was obtained, demonstrating poor chemoselectivity to either C=C or C=O bond reduction. Moreover, a non-negligible amount of cyclohexanone dimethyl ketal (ca. 36.6%) was identified in solution by GC-MS at the end of the run, suggesting that C=O bond protection was competing with hydrogenation under these conditions. When the tests were performed with catalyst 3, low yields (ca. 1%) of hydrogenation products were observed after 24 h at 80 °C. The formation of the corresponding ketal was again observed (ca. 27%).
Hydrogenation of imines and, in particular, cyclic imines is a worthy synthetic tool to obtain amines, that in turn are synthetic intermediates of great importance especially in pharmaceutical industry [25] . Among Ru catalysts described in the literature for this class of homogeneously catalyzed reaction, outstanding performances were obtained for example with Noyori's complex [RuCl(η 6 -p-cymene)(TsDPEN)]
(TsDPEN=N-(p-toluene-sulfonyl)-1,2-diphenylethylenediamine), using a formic acid-triethylamine azeotropic mixture as reducing agent [26, 27] . Examples of water soluble ruthenium-arene catalysts for TH of imines in aqueous phase with HCOONa are also known [28, 29] . For cyclic imines hydrogenation, we also described an efficient system based on a heterogenized Ir(I) complex bearing PTA supported into an ion-exchange resin, using water and H2 pressure [30] .
On the basis of the higher stability demonstrated by complex 3 compared to 1 and 2 under the catalytic conditions previously discussed, this compound was selected as a catalyst for tests in TH of the cyclic imines shown in Table 2 . were at least partially decomposing under these conditions. This was confirmed by repeating the runs using the standard Hg(0) poisoning test which resulted in the reduction of the catalytic activity. This was particularly evident for complex 2, with an important decrease of conversion after 4 h at 80 °C (51.9%, entry 6, vs. 82.6%, entry 5). For comparison, we tested complex RAPTA-C, i.e. the PTA analogue of 1, under the same reaction conditions as in Table 1 , entry 3. Also in this case a substantial drop of conversion was observed in the presence of Hg (30%, entry 10, vs. 99.5% without Hg, entry 9), indicating that a significant degree of decomposition leading to undefined catalytically active phosphine-free species was probably occurring also in the case of RAPTA-C.
On the basis of the higher stability demonstrated by complex 3 compared to 1 and 2 under the catalytic conditions previously discussed, this compound was selected as a catalyst for tests in TH of the cyclic imines shown in Table 2 . The catalytic tests were at first performed with 3,4-dihydroisoquinoline to obtain selectively 1,2,3,4-tetrahydroisoquinoline, a moiety often present in pharmaceutical drugs [31] . As for TH of BZA, a catalyst/substrate/HCOONa ratios of 1:100:1000 were used. The first experiment was carried out in neat water, but as in the case of BZA a MeOH/H2O (1:1) mixture was required to guarantee the formation of a homogeneous phase. In fact, a conversion of only ca. 40% was obtained after 24 h at 80 °C in neat water ( Table 2 , entry 1). On the other hand, when the reaction was carried out in MeOH/H2O (1:1) mixture, the conversion to 1,2,3,4-tetrahydroisoquinoline reached 74.1% after 24 h and 92.5% after 48 h at 80 °C (Table 2, entry 3). As already noted for BZA, a temperature of 80 °C was required to achieve high conversions, as demonstrated by the test performed at 60 °C (Table 2, entry 2) that gave only ca. 11% conversion after 24 h.
The optimized test conditions were used with 3 and three cyclic imines, namely 2-methylquinoxaline, 5-methylquinoxaline, and quinoline (Table 2 , entries 4-6). Disappointingly, these tests showed only minor or no substrate conversion even after 48 h at 80 °C.
As an example of acyclic imine reduction, N-(1-phenylethylidene)aniline was tested with 3 under the conditions described above (see Table 2 caption), but in this case extensive substrate decomposition was observed, in agreement with previous studies with Ir-PTA catalysts [30] .
NMR Mechanistic Studies under Pseudo-Catalytic Conditions
Preliminary mechanistic studies were carried out by NMR spectroscopy with complex 3 under pseudo-catalytic conditions. Firstly, 20 equiv. of HCOONa were added to compound 3 dissolved in MeOH and the resulting orange solution was immediately analyzed by 31 P{ 1 H} NMR. The spectrum showed a singlet at 52.56 ppm, corresponding to unreacted 3, and an accompanying septet at −143.76 ppm due to the PF6 anion. No changes were observed after heating the solution to 60 °C for 2 h; thus, an additional 30 equiv. of HCOONa were added to the reaction mixture and the NMR tube was left standing at 60 °C for 24 h. After this time, the 31 P{ 1 H} NMR spectrum showed complete conversion of 3 to a new species (4) characterized by a singlet at 74.34 ppm and a septet at 143.79 ppm (PF6). The 1 H NMR spectrum gave a triplet in the negative region at 11.43 ppm ( 2 JHP = 35.3 Hz), as expected for the formation of a Ru-H bond. In another test, 3 was reacted directly with 50 equiv. of HCOONa in MeOH/H2O (1:1) at 80° C. After 3 h, in addition to the singlet at 55.77 ppm and the septet at 144.45 The catalytic tests were at first performed with 3,4-dihydroisoquinoline to obtain selectively 1,2,3,4-tetrahydroisoquinoline, a moiety often present in pharmaceutical drugs [31] . As for TH of BZA, a catalyst/substrate/HCOONa ratios of 1:100:1000 were used. The first experiment was carried out in neat water, but as in the case of BZA a MeOH/H2O (1:1) mixture was required to guarantee the formation of a homogeneous phase. In fact, a conversion of only ca. 40% was obtained after 24 h at 80 °C in neat water ( Table 2 , entry 1). On the other hand, when the reaction was carried out in MeOH/H2O (1:1) mixture, the conversion to 1,2,3,4-tetrahydroisoquinoline reached 74.1% after 24 h and 92.5% after 48 h at 80 °C (Table 2, entry 3). As already noted for BZA, a temperature of 80 °C was required to achieve high conversions, as demonstrated by the test performed at 60 °C (Table 2, entry 2) that gave only ca. 11% conversion after 24 h.
Preliminary mechanistic studies were carried out by NMR spectroscopy with complex 3 under pseudo-catalytic conditions. Firstly, 20 equiv. of HCOONa were added to compound 3 dissolved in MeOH and the resulting orange solution was immediately analyzed by 31 P{ 1 H} NMR. The spectrum showed a singlet at 52.56 ppm, corresponding to unreacted 3, and an accompanying septet at −143.76 ppm due to the PF6 anion. No changes were observed after heating the solution to 60 °C for 2 h; thus, an additional 30 equiv. of HCOONa were added to the reaction mixture and the NMR tube was left standing at 60 °C for 24 h. After this time, the 31 P{ 1 H} NMR spectrum showed complete conversion of 3 to a new species (4) The catalytic tests were at first performed with 3,4-dihydroisoquinoline to obtain selectively 1,2,3,4-tetrahydroisoquinoline, a moiety often present in pharmaceutical drugs [31] . As for TH of BZA, a catalyst/substrate/HCOONa ratios of 1:100:1000 were used. The first experiment was carried out in neat water, but as in the case of BZA a MeOH/H2O (1:1) mixture was required to guarantee the formation of a homogeneous phase. In fact, a conversion of only ca. 40% was obtained after 24 h at 80 °C in neat water ( Table 2 , entry 1). On the other hand, when the reaction was carried out in MeOH/H2O (1:1) mixture, the conversion to 1,2,3,4-tetrahydroisoquinoline reached 74.1% after 24 h and 92.5% after 48 h at 80 °C (Table 2, entry 3). As already noted for BZA, a temperature of 80 °C was required to achieve high conversions, as demonstrated by the test performed at 60 °C (Table 2, entry 2) that gave only ca. 11% conversion after 24 h.
Preliminary mechanistic studies were carried out by NMR spectroscopy with complex 3 under pseudo-catalytic conditions. Firstly, 20 equiv. of HCOONa were added to compound 3 dissolved in MeOH and the resulting orange solution was immediately analyzed by 31 P{ 1 H} NMR. The spectrum showed a singlet at 52.56 ppm, corresponding to unreacted 3, and an accompanying septet at −143.76 ppm due to the PF6 anion. No changes were observed after heating the solution to 60 °C for 2 h; thus, an additional 30 equiv. of HCOONa were added to the reaction mixture and the NMR tube was left standing at 60 °C for 24 h. After this time, the 31 P{ 1 H} NMR spectrum showed complete conversion of 3 to a new species (4) characterized by a singlet at 74.34 ppm and a septet at 143.79 ppm (PF6). The catalytic tests were at first performed with 3,4-dihydroisoquinoline to obtain selectively 1,2,3,4-tetrahydroisoquinoline, a moiety often present in pharmaceutical drugs [31] . As for TH of BZA, a catalyst/substrate/HCOONa ratios of 1:100:1000 were used. The first experiment was carried out in neat water, but as in the case of BZA a MeOH/H2O (1:1) mixture was required to guarantee the formation of a homogeneous phase. In fact, a conversion of only ca. 40% was obtained after 24 h at 80 °C in neat water ( Table 2 , entry 1). On the other hand, when the reaction was carried out in MeOH/H2O (1:1) mixture, the conversion to 1,2,3,4-tetrahydroisoquinoline reached 74.1% after 24 h and 92.5% after 48 h at 80 °C (Table 2, entry 3). As already noted for BZA, a temperature of 80 °C was required to achieve high conversions, as demonstrated by the test performed at 60 °C (Table 2, entry 2) that gave only ca. 11% conversion after 24 h.
Preliminary mechanistic studies were carried out by NMR spectroscopy with complex 3 under pseudo-catalytic conditions. Firstly, 20 equiv. of HCOONa were added to compound 3 dissolved in MeOH and the resulting orange solution was immediately analyzed by 31 P{ 1 H} NMR. The spectrum showed a singlet at 52.56 ppm, corresponding to unreacted 3, and an accompanying septet at −143.76 ppm due to the PF6 anion. No changes were observed after heating the solution to 60 °C for 2 h; thus, an additional 30 equiv. of HCOONa were added to the reaction mixture and the NMR tube was left standing at 60 °C for 24 h. After this time, the 31 P{ 1 H} NMR spectrum showed complete conversion of 3 to a new species (4) characterized by a singlet at 74.34 ppm and a septet at 143.79 ppm (PF6). The 1 H NMR spectrum gave a triplet in the negative region at 11.43 ppm ( 2 JHP = 35.3 Hz), as expected for the formation of a Ru-H bond. In another test, 3 was reacted directly with 50 equiv. of HCOONa in MeOH/H2O (1:1) at 80° C. After 3 h, in addition to the singlet at 55.77 ppm and the septet at 144.45 The catalytic tests were at first performed with 3,4-dihydroisoquinoline to obtain selectively 1,2,3,4-tetrahydroisoquinoline, a moiety often present in pharmaceutical drugs [31] . As for TH of BZA, a catalyst/substrate/HCOONa ratios of 1:100:1000 were used. The first experiment was carried out in neat water, but as in the case of BZA a MeOH/H 2 O (1:1) mixture was required to guarantee the formation of a homogeneous phase. In fact, a conversion of only ca. 40% was obtained after 24 h at 80 • C in neat water ( Table 2 , entry 1). On the other hand, when the reaction was carried out in MeOH/H 2 O (1:1) mixture, the conversion to 1,2,3,4-tetrahydroisoquinoline reached 74.1% after 24 h and 92.5% after 48 h at 80 • C (Table 2, entry 3). As already noted for BZA, a temperature of 80 • C was required to achieve high conversions, as demonstrated by the test performed at 60 • C (Table 2, entry 2) that gave only ca. 11% conversion after 24 h.
The optimized test conditions were used with 3 and three cyclic imines, namely 2-methylquinoxaline, 5-methylquinoxaline, and quinoline (Table 2 , entries 4-6). Disappointingly, these tests showed only minor or no substrate conversion even after 48 h at 80 • C.
Preliminary mechanistic studies were carried out by NMR spectroscopy with complex 3 under pseudo-catalytic conditions. Firstly, 20 equiv. of HCOONa were added to compound 3 dissolved in MeOH and the resulting orange solution was immediately analyzed by 31 P{ 1 H} NMR. The spectrum showed a singlet at 52.56 ppm, corresponding to unreacted 3, and an accompanying septet at −143.76 ppm due to the PF 6 anion. No changes were observed after heating the solution to 60 • C for 2 h; thus, an additional 30 equiv. of HCOONa were added to the reaction mixture and the NMR tube was left standing at 60 • C for 24 h. After this time, the 31 P{ 1 H} NMR spectrum showed complete conversion of 3 to a new species (4) characterized by a singlet at 74.34 ppm and a septet at −143.79 ppm (PF 6 [32] , we attribute the new pattern to the formation of the cationic monohydrido complex κP-[RuH(η 6 -p-cymene)(CAP) 2 ](PF 6 ) (4, Scheme 2). A confirmation of this attribution came from the independent synthesis of 4 (see Experimental Section).
A final NMR scale experiment was carried out with 3 and HCOONa (1:50 ratio) under the same conditions of solvents (MeOH/H 2 O 1:1) and temperature (80 • C) described above, adding 3,4-dihydroisoquinoline (5 equiv. to 3) to the mixture before heating. The pattern due to 4 was observed initially after 4 h, to become the only P-containing species after 24 h. The conversion of the imine to the corresponding amine 1,2,3,4-tetrahydroisoquinoline was confirmed by GC-MS analysis of the crude mixture after 24 h. (Figure 3 ). Based on this evidence and by comparison with data reported for [RuCp(H)(PTA)2], whose hydride signal was identified by 1 H NMR as a triplet at 14.36 ppm ( 2 JHP = 36.6 Hz) in CD2Cl2 [32] , we attribute the new pattern to the formation of the cationic monohydrido complex P-[RuH( 6 -p-cymene)(CAP)2](PF6) (4, Scheme 2). A confirmation of this attribution came from the independent synthesis of 4 (see Experimental Section).
A final NMR scale experiment was carried out with 3 and HCOONa (1:50 ratio) under the same conditions of solvents (MeOH/H2O 1:1) and temperature (80 °C) described above, adding 3,4-dihydroisoquinoline (5 equiv. to 3) to the mixture before heating. The pattern due to 4 was observed initially after 4 h, to become the only P-containing species after 24 h. The conversion of the imine to the corresponding amine 1,2,3,4-tetrahydroisoquinoline was confirmed by GC-MS analysis of the crude mixture after 24 h. 
Experimental Section
Materials and Methods
All manipulations were carried out under a purified N2 atmosphere using standard Schlenk techniques unless otherwise noted. Deuterated solvents and other reagents were bought from commercial suppliers and used without further purification. Doubly distilled water was used. All solvents were distilled, dried, and degassed prior to use. Compounds Catalysts 2018, 8, x FOR PEER REVIEW 6 of 10 ppm due to 3 (slight differences in the chemical shift values derive from the use of MeOH/H2O mixture instead of pure MeOH), the singlet due to 4 was detected in the 31 P{ 1 H} NMR spectrum at 78.26 ppm, in 4:1 ratio with 3. Complete conversion of 3 to 4 was reached after leaving the tube standing at 80 °C for 17 h. Upon solvent removal in vacuo, and dissolving the obtained solid in CD2Cl2, the 31 P{ 1 H} NMR spectrum of 4 showed a singlet at 67.66 ppm and a septet at 149.50 ( 1 JPF = 711 Hz) ppm due to PF6. The corresponding 1 H NMR spectrum showed in the negative region a triplet at 12.23 ppm ( 2 JHP = 35.5 Hz) which became a singlet in the corresponding P-decoupled 1 H { 31 P} NMR spectrum ( Figure 3 ). Based on this evidence and by comparison with data reported for [RuCp(H)(PTA)2], whose hydride signal was identified by 1 H NMR as a triplet at 14.36 ppm ( 2 JHP = 36.6 Hz) in CD2Cl2 [32] , we attribute the new pattern to the formation of the cationic monohydrido complex P-[RuH( 6 -p-cymene)(CAP)2](PF6) (4, Scheme 2). A confirmation of this attribution came from the independent synthesis of 4 (see Experimental Section).
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Materials and Methods
All manipulations were carried out under a purified N 2 atmosphere using standard Schlenk techniques unless otherwise noted. Deuterated solvents and other reagents were bought from commercial suppliers and used without further purification. Doubly distilled water was used. All solvents were distilled, dried, and degassed prior to use. Compounds κP-[RuCl 2 (η 6 -p-cymene)(CAP)] (1), κP-[RuCl(η 6 -p-cymene)(MeCN)(CAP)](PF 6 ) (2), κP-[RuCl(η 6 -p-cymene)(CAP) 2 ](PF 6 ) (3) [22] , RAPTA-C [33] and [RuCl 2 (η 6 -p-cymene)] 2 [34] were prepared as described in the literature. 1 H and
